Overall, the presence of CD16 on exosomes derived from both monocytic and tumor cells provided the basis for investigating levels of CD16 on exosomes from HNSCC patients to examine their role in modulating the TME. The gene discussed is FCGR3A; the disease is head and neck squamous cell carcinoma.